基于Beers标准的合理用药审查工具干预对社区老年慢性病病人的效果评价

    Evaluation of the effect of the review tool intervention on the reasonable medication in community senile patients with chronic diseases

    • 摘要: 目的:基于Beers标准,对社区老年慢性病病人实施合理用药审查工具干预的效果进行评价。方法:随机选择某社区老年慢性病病人200例,按照随机数字表法分为干预组103例和对照组97例。对照组病人接受常规用药指导,干预组病人基于Beers标准接受合理用药审查工具干预。观察并比较2组病人用药情况。结果:2组病人干预前药物治疗收益情况和生命健康质量各项指标差异均无统计学意义(P>0.05)。干预后,干预组病人药物不良反应、用药数量和用药费用均明显少于对照组(P<0.01),而依从性显著优于对照组(P<0.01),2组病人超适应症用药差异无统计学意义(P>0.05);干预组病人生命健康质量各项评价指标亦均优于对照组(P<0.05~P<0.01)。结论:基于Beers标准,在社区老年慢性病病人中实施合理用药审查工具干预,不仅用药安全有效,同时也减轻病人经济负担,并有利于病人生命健康质量的提升,具有进一步推广价值。

       

      Abstract: Objective:To evaluate the effects of the review tool intervention on the reasonable medication in community senile patients with chronic diseases based on Beers standard.Methods:Two hundred community senile patients with chronic diseases were randomly selected,and divided into the control group(103 cases) and intervention group(97 cases).The control group were instructed with routine medication,and the intervention group were instructed with the review tool intervention of the reasonable medication based on the Beers standard.The medication between two groups was compared.Results:The differences of the benefit of medication and indicators of life quality before intervention between two groups were not statistically significant(P>0.05).After intervention,the adverse reactions,amount and cost of medication in intervention group were significantly less than those in control group(P<0.01),but the compliance of medication in intervention group was significantly better than that in control group(P<0.01).The difference of the super indications medication between two groups was not statistically significant(P>0.05).The indicators of life quality in intervention group was better than that in control group(P<0.05 to P<0.01).Conclusions:The review tool intervention of the reasonable medication in community senile patients with chronic diseases based on Beers standard is safe and effective,which can lighten the financial burden and improve the quality of life and health of patients,and is worth popularizing.

       

    /

    返回文章
    返回